High frequency of alterations in DNA methylation in adenocarcinoma of the prostate

Prostate

Volumn 39, Issue 3, 1999, Pages 166-174

  Santourlidis, Simon ^a   Florl, Andrea ^a   Ackermann, Rolf ^a   Wirtz, Hans Christian ^a   Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

DNA hypomethylation; Genomic instability; Glutathione transferase; L1 retrotransposon; Prognosis

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; DNA METHYLATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RETROPOSON; SOUTHERN BLOTTING;

ADENOCARCINOMA; AGED; BLOTTING, SOUTHERN; DNA METHYLATION; GENETIC MARKERS; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS;

EID: 0033135573     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990515)39:3<166::AID-PROS4>3.0.CO;2-J     Document Type: Article

References (24)

1. Laird PW. The role of DNA methylation in cancer genetics and epigenetics. Ann Rev Genet 1996;30:441-464.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-196.
3. Schulz WA. DNA methylation in urological malignancies. Int J Oncol 1998;13:151-167.
4. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997;13:335-340.
5. Jürgens B, Schmitz-Dräger BJ, Schulz WA. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 1996;56:5698-5703.
6. Bedford MT, van Helden PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 1987; 47:5274-5276.
7. Tolberg ME, Funderburk SJ, Klisak I, Smith SS. Structural organization and DNA methylation patterning within the mouse L1 family. J Biol Chem 1987;262:11167-11175.
8. Woodcock DM, Lawler CB, Linsenmeyer ME, Doherty JP, Warren WD. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem 1997;272:7810-7816.
9. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 1988;355:87-90.
10. Holmes SE, Dombroski BA, Krebs CM, Boehm CD, Kazazian HH. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet 1994;7:143-148.
11. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992;52:643-645.
12. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994;91:11733-11737.
13. MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 1996;35:55-65.
14. Morton RA, Watkins JJ, Bova GS, Wales MM, Baylin SB, Isaacs WB. Hypermethylation of chromosome 17p locus D17S5 in human prostate tissue. J Urol 1996;156:512-516.
15. Jarrard DF, Bova GS, Ewing CM, Pin SS, Nguyen SH, Baylin SB, Cairns P, Sidransky D, Herman JG, Isaacs WB. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTSI) in primary and metastatic prostate cancer. Genes Chromosomes Cancer 1997;19:90-96.
16. Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 1997;57:35-37.
17. Lee WH, Isaacs WB, Bova GS, Nelson WG. CpG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997;6: 443-450.
18. Xia C, Hu J, Ketterer B, Taylor JB. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J 1996;313:155-161.
19. Strohmeyer T, Klöne A, Wagner G, Hartmann M, Sies H. Glutathione S-transferases in human testicular germ cell tumors. Changes of expression and activity. J Urol 1992;147:1424-1428.
20. Eickelmann P, Ebert T, Warskulat U, Schulz WA, Sies H. Expression of NAD(P)H: quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 1994;15:219-225.
21. Dombroski BA, Scott AF, Kazazian HH. Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc Natl Acad Sci USA 1993;90:6513-6517.
22. Steigerwald SD, Pfeifer GP, Riggs AD. Ligation-mediated PCR improves the sensitivity of methylation analysis by restriction enzymes and detection of specific DNA strand breaks. Nucleic Acids Res 1990;18:1435-1439.
23. Jarrard DF, Bova GS, Isaacs WB. DNA methylation, molecular genetic, and linkage studies in prostate cancer. Prostate [Suppl] 1996;6:36-44.
24. Jones PA, Gonzalgo ML. Altered DNA methylation and genome instability: a new pathway to cancer? Proc Natl Acad Sci USA 1997;94:2103-2105.